Pain Management Drug Market Revenue Will Reach $48.40 Billion in 2023

Pain management drugs refer to drugs that can partially or completely alleviate pain. Common pain management drugs include aspirin, painkillers, paracetamol, prednisone, and rofecoxib. The use of pain management drugs should follow the advice and guidance of a doctor, and should not be used or abused indiscriminately. In addition, before using any medication, it is important to carefully read the drug instructions to understand the usage, dosage, and potential side effects of the medication.

Analysis of the Global Pain Management Drug Segmentation Market

According to the different types, specifications, indications, doses, and administration routes of drugs, pain management drugs can be divided into two categories: over-the-counter pain management drugs and prescription pain management drugs. Over-the-counter pain management drugs can usually be purchased at pharmacies without a doctor's prescription. Common over-the-counter pain management drugs include aspirin, ibuprofen, naproxen, etc. They can alleviate mild to moderate pain, such as headaches, toothache, joint pain, etc. For some severe pain, doctors may need to prescribe drugs. These drugs usually require guidance from a doctor or pharmacist before use. Common prescription pain management drugs include codeine, hydrocodone, fentanyl, etc. They can be used to alleviate moderate to severe pain, such as postoperative pain, cancer pain, etc.

Research has shown that over-the-counter pain management drugs have a higher market share among the two types. According to our research data, the global over-the-counter pain management drug segment is expected to generate revenue of $28.47 billion in 2023, with a market share of 58.81%.

Global Pain Management Drug Market Revenue and Share Forecast by Type and Therapeutic Indication in 2023

Source: www.globalmarketmonitor.com